Long-Term Oncological Outcomes in Intermediate-Risk Cervical Cancer After Radical Surgery: A Single-Center Retrospective Cohort Study
Cancers · 12.11.2026 · 18 (22) · 3612
DOI: 10.3390/cancers18223612 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancers, online erschienen am 12.11.2026. Verfasst von Ádám Tabányi und 11 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The optimal postoperative management of intermediate-risk cervical cancer remains uncertain. We aimed to describe long-term outcomes and explore differences by postoperative treatment.
Methods
This single-center retrospective cohort study included patients undergoing radical hysterectomy and pelvic lymph node assessment who fulfilled intermediate-risk criteria aligned with the CERVANTES trial. Disease-free survival (DFS) was the primary outcome and overall survival (OS) the secondary outcome. Observed 3- and 5-year survival proportions were compared among patients with documented follow-up at each time point.
Results
Of 186 patients undergoing primary surgery, 41 fulfilled the intermediate-risk criteria: 30 were managed with surgery alone and 11 received adjuvant treatment. Median maximum tumor diameter was smaller in the surgery-alone group than in the adjuvant-treatment group (28.5 mm [IQR, 24.25–34.00] vs. 41.0 mm [IQR, 33.5–47.5]; p = 0.003), and FIGO stage IB3 was less frequent (6.7% vs. 63.6%; p < 0.001). No recurrences or deaths occurred in the surgery-alone group. One patient in the adjuvant-treatment group died from an unrelated cause; this was the only DFS event. At 3 years, observed OS and DFS were 100% (23/23) in the surgery-alone group and 90.0% (9/10) in the adjuvant-treatment group (p = 0.303). At 5 years, the corresponding proportions were 100% (16/16) and 85.7% (6/7; p = 0.304).
Conclusions
Patients managed with surgery alone had favorable observed outcomes. However, baseline risk differed between groups, and time-point proportions included only patients with documented follow-up. The retrospective design, small sample, and non-randomized allocation preclude conclusions about the comparative effectiveness or safety of omitting adjuvant treatment. Prospective randomized studies are needed.
Zitieren
APA
Tabányi, Á., Sebok, P., Lotti, L., Tóth, R., Bánhidy, F., Kárpáti, C., Molnár-Csendom, Á., Căpîlna, D. M., Kiss, S. L., Vida, B., Keszthelyi, M., & Lintner, B. (2026). Long-Term Oncological Outcomes in Intermediate-Risk Cervical Cancer After Radical Surgery: A Single-Center Retrospective Cohort Study. Cancers, 18(22), 3612. https://doi.org/10.3390/cancers18223612
Vancouver
Tabányi Á, Sebok P, Lotti L, Tóth R, Bánhidy F, Kárpáti C, et al. Long-Term Oncological Outcomes in Intermediate-Risk Cervical Cancer After Radical Surgery: A Single-Center Retrospective Cohort Study. Cancers. 2026;18(22):3612. doi:10.3390/cancers18223612
BibTeX
@article{Tabnyi2026,
author = {Tabányi, Ádám and Sebok, Pál and Lotti, Lőczi and Tóth, Richárd and Bánhidy, Francis and Kárpáti, Csongor and Molnár-Csendom, Ákos and Căpîlna, Dan Mihai and Kiss, Szilard Leo and Vida, Balázs and Keszthelyi, Márton and Lintner, Balázs},
title = {Long-Term Oncological Outcomes in Intermediate-Risk Cervical Cancer After Radical Surgery: A Single-Center Retrospective Cohort Study},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3612},
doi = {10.3390/cancers18223612}
}
EUVIMED